HCA-affiliated Drs. Michael Snyder and Matthew Brengman are two of only a select few bariatric surgeons trained on the newly approved ORBERA Intragastric Balloon weight loss procedure. The procedure was approved by the U.S. Food and Drug Administration (FDA) in August. Both doctors were involved in the FDA trial of the gastric balloon. We followed up with them to learn more about obesity, the new procedure and how it differs from other weight loss surgeries. Dr. Michael Snyder Q: Why are we or should we be concerned about obesity? A: There are nearly two billion adults who are overweight or… Read more.